ARCHIVES

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | March 19, 1999

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

Also in this 8-page issue: NCI informatics project caBIG will “rapidly accelerate” cancer research, von Eschenbach says.

March 12, 2004

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

January 16, 2009

In Brief: David Sundial Named Health Director Of Senate Labor & Human Resources Committee’s HHS Office

September 20, 1985

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991